Antibe Therapeutics Inc.
ATE
Helyezés a részvények között
#31779
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Részvényárfolyam
$0.21483059
Utolsó szinkronizálás: 2024-05-07
Piaci kapitalizáció
$11.13M
Változás (1 nap)
0.34%
Változás (1 év)
-0.36%
Ország
CA
Kereskedés Antibe Therapeutics Inc. (ATE)
Kategória
Healthcare
Antibe Therapeutics Inc. (ATE) részvényárfolyamának története
Legmagasabb napi záróár: $0.22 ekkor: 2025-04-01
Legalacsonyabb napi záróár: $4.78 ekkor: 2014-10-01
Legalacsonyabb napi záróár: $4.78 ekkor: 2014-10-01
Antibe Therapeutics Inc. részvényárfolyamának története 2014 és 2026 között
Éves részvényárfolyam teljesítmény
| Év | Teljesítmény |
|---|---|
| 2025 | -0.02% |
| 2024 | -64.79% |
| 2023 | 73.56% |
| 2022 | -33.35% |
| 2021 | -82.11% |
| 2020 | -6.13% |
| 2019 | 60.42% |
| 2018 | 70.25% |
| 2017 | -45.71% |
| 2016 | 86.85% |
| 2015 | -71.73% |
| 2014 | 0.00% |
Hasonló cégek vagy versenytársak részvényárai
| Vállalat | Részvényár | Változás 1év% | Ország |
|---|---|---|---|
| $102.16 | -20.16% |
US
|
|
| $95.93 | 0.03% |
IE
|
|
| $308.30 | -20.61% |
US
|
|
| $45.61 | -56.08% |
US
|
|
| $47.05 | -17.88% |
DE
|
